Table 6.

Multivariate analysis of risk factors for survival in patients with a C-P score of 12-15

Variable	HR	95% CI	p Value
Treatment
LAT vs. BSC	0.361	0.17–0.68	0.0014
TACE vs. BSC	0.517	0.33–0.78	0.0018
Age (years)
<60 vs. ≥60	0.89	0.59–1.30	0.5674
AFP (ng/ml)
≤200 vs. >200	0.533	0.37–0.76	0.0008
Maximum tumor size (cm)
≤2.0 vs. 2.1–3.0	0.957	0.52–1.73	0.8879
≤2.0 vs. ≥3.1	0.622	0.35–1.03	0.0664